Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Eligible studies were cohort or case-control studies that assessed maternal exposure to GLP-1 receptor agonists from 90 days before conception through the end of pregnancy and included an appropriate unexposed comparator group
We also like to see that youve tried diet and exercise without lasting success, and that youre ready to pair the medication with real lifestyle changes it works with you, not instead of you
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
Compounded drugs are permitted under Section 503A/503B and are prepared by licensed pharmacies, but the FDA has not evaluated them for safety, effectiveness, or quality
Our guide on pregnancy and tirzepatide covers this important topic in depth
As with any medication, patients often have concerns about possible side effects
